269 related articles for article (PubMed ID: 25582170)
21. Molecular therapy in pancreatic adenocarcinoma.
MacKenzie MJ
Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
[TBL] [Abstract][Full Text] [Related]
22. Innovative treatments for pancreatic cancer.
Lieberman SM; Hörig H; Kaufman HL
Surg Clin North Am; 2001 Jun; 81(3):715-39. PubMed ID: 11459285
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic viral therapy for pancreatic cancer.
Rahal A; Musher B
J Surg Oncol; 2017 Jul; 116(1):94-103. PubMed ID: 28407327
[TBL] [Abstract][Full Text] [Related]
24. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer.
Zhang Z; Huang Y; Newman K; Gu J; Zhang X; Wu H; Zhao M; Xianyu Z; Liu X
Clin Cancer Res; 2009 Aug; 15(16):5154-60. PubMed ID: 19671855
[TBL] [Abstract][Full Text] [Related]
25. Combinational therapy: new hope for pancreatic cancer?
Shi S; Yao W; Xu J; Long J; Liu C; Yu X
Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436
[TBL] [Abstract][Full Text] [Related]
26. Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
Segelov E; Lordick F; Goldstein D; Chantrill LA; Croagh D; Lawrence B; Arnold D; Chau I; Obermannova R; Price TJ
Expert Rev Anticancer Ther; 2017 Oct; 17(10):951-964. PubMed ID: 28817982
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy in pancreatic cancer - current status and future.
Staib L; Link KH; Beger HG
Langenbecks Arch Surg; 1999 Aug; 384(4):396-404. PubMed ID: 10473862
[TBL] [Abstract][Full Text] [Related]
28. T cell optimization for the treatment of pancreatic cancer.
Liu F; Saif MW
Expert Opin Biol Ther; 2017 Dec; 17(12):1493-1501. PubMed ID: 28835191
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy for cancer treatment: past, present and future.
Cross D; Burmester JK
Clin Med Res; 2006 Sep; 4(3):218-27. PubMed ID: 16988102
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy in pancreatic cancer.
Liu SX; Xia ZS; Zhong YQ
World J Gastroenterol; 2014 Oct; 20(37):13343-68. PubMed ID: 25309069
[TBL] [Abstract][Full Text] [Related]
31. Biotherapeutic approaches to pancreatic cancer.
Rosenberg L; Lipsett M
Expert Opin Biol Ther; 2003 Apr; 3(2):319-37. PubMed ID: 12662145
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy: opportunities, risks and future perspectives.
Hildebrandt M; Peggs K; Uharek L; Bollard CM; Heslop HE
Cytotherapy; 2014 Apr; 16(4 Suppl):S120-9. PubMed ID: 24629797
[TBL] [Abstract][Full Text] [Related]
33. Advances in gene therapy and immunotherapy for brain tumors.
Kew Y; Levin VA
Curr Opin Neurol; 2003 Dec; 16(6):665-70. PubMed ID: 14624074
[TBL] [Abstract][Full Text] [Related]
34. The potential of oncolytic virus therapy for pancreatic cancer.
Kasuya H; Takeda S; Nomoto S; Nakao A
Cancer Gene Ther; 2005 Sep; 12(9):725-36. PubMed ID: 15818382
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy.
Takao S; Ding Q; Matsubara S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):614-20. PubMed ID: 22878838
[TBL] [Abstract][Full Text] [Related]
36. Targeted therapy for stress urinary incontinence: a systematic review based on clinical trials.
Pokrywczynska M; Adamowicz J; Czapiewska M; Balcerczyk D; Jundzill A; Nowacki M; Petros P; Drewa T
Expert Opin Biol Ther; 2016; 16(2):233-42. PubMed ID: 26560683
[TBL] [Abstract][Full Text] [Related]
37. Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy.
Galanopoulos M; Doukatas A; Gkeros F; Viazis N; Liatsos C
World J Gastroenterol; 2021 Jun; 27(24):3568-3580. PubMed ID: 34239270
[TBL] [Abstract][Full Text] [Related]
38. Emerging antibodies for the treatment of pancreatic cancer.
Andrikou K; Peterle C; Pipitone S; Salati M; Cascinu S
Expert Opin Emerg Drugs; 2017 Mar; 22(1):39-51. PubMed ID: 28253833
[TBL] [Abstract][Full Text] [Related]
39. Molecular targeted approaches for treatment of pancreatic cancer.
Huang ZQ; Saluja AK; Dudeja V; Vickers SM; Buchsbaum DJ
Curr Pharm Des; 2011; 17(21):2221-38. PubMed ID: 21777178
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
